114 related articles for article (PubMed ID: 35455252)
1. Human Papillomavirus Vaccine Hesitancy Highly Evident among Caregivers of Girls Attending South African Private Schools.
Milondzo T; Meyer JC; Dochez C; Burnett RJ
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455252
[TBL] [Abstract][Full Text] [Related]
2. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
Milondzo T; Meyer JC; Dochez C; Burnett RJ
Front Public Health; 2021; 9():598625. PubMed ID: 33681125
[No Abstract] [Full Text] [Related]
3. Vaccine Hesitancy Drives Low Human Papillomavirus Vaccination Coverage in Girls Attending Public Schools in South Africa.
Khosa LA; Meyer JC; Motshwane FMM; Dochez C; Burnett RJ
Front Public Health; 2022; 10():860809. PubMed ID: 35685759
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
Front Public Health; 2022; 10():799984. PubMed ID: 35174123
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) vaccination of adolescents in the South African private health sector: Lessons from the HPV demonstration project in KwaZulu-Natal.
Tathiah N; Naidoo M; Moodley I
S Afr Med J; 2015 Nov; 105(11):954. PubMed ID: 26937512
[TBL] [Abstract][Full Text] [Related]
7. Social media and HPV vaccination: Unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa.
Wiyeh AB; Cooper S; Jaca A; Mavundza E; Ndwandwe D; Wiysonge CS
Vaccine; 2019 Oct; 37(43):6317-6323. PubMed ID: 31521412
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Vaccination and Social Media: Results in a Trial With Mothers of Daughters Aged 14-17.
Buller DB; Pagoto S; Henry K; Berteletti J; Walkosz BJ; Bibeau J; Baker K; Hillhouse J; Arroyo KM
Front Digit Health; 2021; 3():683034. PubMed ID: 34713152
[No Abstract] [Full Text] [Related]
9. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016).
Hirth JM; Fuchs EL; Chang M; Fernandez ME; Berenson AB
Vaccine; 2019 Jan; 37(4):595-601. PubMed ID: 30580838
[TBL] [Abstract][Full Text] [Related]
10. Malawian caregivers' experiences with HPV vaccination for preadolescent girls: A qualitative study.
Moucheraud C; Whitehead HS; Songo J; Szilagyi PG; Hoffman RM; Kaunda-Khangamwa BN
Vaccine X; 2023 Aug; 14():100315. PubMed ID: 37251590
[TBL] [Abstract][Full Text] [Related]
11. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
[TBL] [Abstract][Full Text] [Related]
12. Performance of the school-based human papillomavirus vaccine uptake in Tshwane, South Africa.
Ledibane TD; Ledibane NR; Matlala M
S Afr J Infect Dis; 2023; 38(1):492. PubMed ID: 36756242
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.
Ngcobo NJ; Burnett RJ; Cooper S; Wiysonge CS
S Afr Med J; 2018 Dec; 109(1):13-15. PubMed ID: 30606297
[TBL] [Abstract][Full Text] [Related]
14. Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.
Patrick L; Bakeera-Kitaka S; Rujumba J; Malande OO
PLoS One; 2022; 17(6):e0269655. PubMed ID: 35679304
[TBL] [Abstract][Full Text] [Related]
15. Caregivers' Willingness to Vaccinate Their Children against Childhood Diseases and Human Papillomavirus: A Cross-Sectional Study on Vaccine Hesitancy in Malawi.
Adeyanju GC; Sprengholz P; Betsch C; Essoh TA
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835162
[TBL] [Abstract][Full Text] [Related]
16. Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines.
Vercruysse J; Chigurupati NL; Fung L; Apte G; Pierre-Joseph N; Perkins RB
Hum Vaccin Immunother; 2016 Jun; 12(6):1606-14. PubMed ID: 26934421
[TBL] [Abstract][Full Text] [Related]
17. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
[TBL] [Abstract][Full Text] [Related]
18. Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.
Selvey LA; Roux F; Burns S
Vaccine; 2020 Mar; 38(14):2971-2977. PubMed ID: 32115296
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.
Li X; Stander MP; Van Kriekinge G; Demarteau N
BMC Infect Dis; 2015 Dec; 15():566. PubMed ID: 26652918
[TBL] [Abstract][Full Text] [Related]
20. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study.
Watson-Jones D; Tomlin K; Remes P; Baisley K; Ponsiano R; Soteli S; de Sanjosé S; Changalucha J; Kapiga S; Hayes RJ
PLoS One; 2012; 7(10):e45231. PubMed ID: 23115621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
